Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Oderda

Showing results (101-110 of 175) with videos related to

Pageof 18
Sort By:
European Urology Open Science|June 17, 2025
Robot-assisted Management of Complex Ureteral Stenosis in Kidney Transplant Patients: Multicenter Case Series and Description of Surgical TechniquesJoris Vangeneugden, Federico Lavagno, Camille Berquin, et al.
Current Oncology (Toronto, Ont.)|July 26, 2024
MRI-Targeted Prostate Fusion Biopsy: What Are We Missing outside the Target? Implications for Treatment PlanningMarco Oderda, Alessandro Dematteis, Giorgio Calleris, et al.
British Journal of Cancer|December 14, 2016
Increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of bladder cancerBarbara Pardini, Clara Viberti, Alessio Naccarati, et al.
The Prostate|December 12, 2024
Histopathologic Features and Transcriptomic Signatures Do Not Solve the Issue of Magnetic Resonance Imaging-Invisible Prostate Cancers: A Matched-Pair AnalysisMarco Oderda, Alessandro Marquis, Luca Bertero, et al.
European Urology Open Science|January 5, 2023
Topography of Prostate Cancer Recurrence: A Single-centre Analysis of Salvage Radical Prostatectomy Specimens and Implications for Focal Salvage TreatmentsGiancarlo Marra, Giorgio Calleris, Emilia Massari, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2025
Recent Advances in Androgen Receptor Pathway Inhibitors for Castration-Sensitive Prostate CancerAndrea Lancia, Marco Oderda, Federico Camilli, et al.
Cancers|June 13, 2020
Small Non-Coding RNA Profiling in Plasma Extracellular Vesicles of Bladder Cancer Patients by Next-Generation Sequencing: Expression Levels of miR-126-3p and piR-5936 Increase with Higher Histologic GradesAlexandru A Sabo, Giovanni Birolo, Alessio Naccarati, et al.
European Radiology|June 12, 2020
Clinico-radiological characteristic-based machine learning in reducing unnecessary prostate biopsies of PI-RADS 3 lesions with dual validationYansheng Kan, Qing Zhang, Jiange Hao, et al.
Translational Andrology and Urology|October 11, 2022
Ki-67, topoisomerase IIα and miR-221 have a limited prostate cancer risk stratification ability on a medium-term follow-up: results of a high-risk radical prostatectomy cohortGiancarlo Marra, Marco Oderda, Giorgio Calleris, et al.
World Journal of Urology|September 25, 2021
COVID-19 pandemic impact on uro-oncological disease outcomes at an Italian tertiary referral centerMarco Oderda, Francesco Soria, Francesco Rosi, et al.
Pageof 18

Showing results (101-110 of 175) with videos related to

Sort By:
Pageof 18
European Urology Open Science|June 17, 2025
Robot-assisted Management of Complex Ureteral Stenosis in Kidney Transplant Patients: Multicenter Case Series and Description of Surgical TechniquesJoris Vangeneugden, Federico Lavagno, Camille Berquin, et al.
Current Oncology (Toronto, Ont.)|July 26, 2024
MRI-Targeted Prostate Fusion Biopsy: What Are We Missing outside the Target? Implications for Treatment PlanningMarco Oderda, Alessandro Dematteis, Giorgio Calleris, et al.
British Journal of Cancer|December 14, 2016
Increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of bladder cancerBarbara Pardini, Clara Viberti, Alessio Naccarati, et al.
The Prostate|December 12, 2024
Histopathologic Features and Transcriptomic Signatures Do Not Solve the Issue of Magnetic Resonance Imaging-Invisible Prostate Cancers: A Matched-Pair AnalysisMarco Oderda, Alessandro Marquis, Luca Bertero, et al.
European Urology Open Science|January 5, 2023
Topography of Prostate Cancer Recurrence: A Single-centre Analysis of Salvage Radical Prostatectomy Specimens and Implications for Focal Salvage TreatmentsGiancarlo Marra, Giorgio Calleris, Emilia Massari, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2025
Recent Advances in Androgen Receptor Pathway Inhibitors for Castration-Sensitive Prostate CancerAndrea Lancia, Marco Oderda, Federico Camilli, et al.
Cancers|June 13, 2020
Small Non-Coding RNA Profiling in Plasma Extracellular Vesicles of Bladder Cancer Patients by Next-Generation Sequencing: Expression Levels of miR-126-3p and piR-5936 Increase with Higher Histologic GradesAlexandru A Sabo, Giovanni Birolo, Alessio Naccarati, et al.
European Radiology|June 12, 2020
Clinico-radiological characteristic-based machine learning in reducing unnecessary prostate biopsies of PI-RADS 3 lesions with dual validationYansheng Kan, Qing Zhang, Jiange Hao, et al.
Translational Andrology and Urology|October 11, 2022
Ki-67, topoisomerase IIα and miR-221 have a limited prostate cancer risk stratification ability on a medium-term follow-up: results of a high-risk radical prostatectomy cohortGiancarlo Marra, Marco Oderda, Giorgio Calleris, et al.
World Journal of Urology|September 25, 2021
COVID-19 pandemic impact on uro-oncological disease outcomes at an Italian tertiary referral centerMarco Oderda, Francesco Soria, Francesco Rosi, et al.
Pageof 18